The 8th Iran Pharmex International Exhibition 2026 has opened with the participation of three knowledge-based companies—Faran Shimi, Soroush Mana Pharmed, and Hasti Arya Shimi—all subsidiaries of Golrang Pharmaceutical Investment Group.
According to the Public Relations Department of Golrang Pharmaceutical Group, the exhibition is being held from September 8 to 10 at the Iran Mall Exhibition Center, bringing together professionals and specialists from the pharmaceutical industry.
As exhibition sponsors, the three Golrang Group companies are showcasing their latest capabilities and achievements in the production of Active Pharmaceutical Ingredients (APIs), the development of technical know-how, and the completion of the pharmaceutical supply chain.
Leveraging the capabilities of its knowledge-based companies, Golrang Pharmaceutical Group is active in the production of APIs for opioid medicines, products related to diabetes and dialysis, the domestic production of ingredients such as mesalazine and linagliptin, and the development of other knowledge-based products. Expanding export markets and reducing dependence on imported pharmaceutical raw materials are also key priorities for the Group as it works to complete the pharmaceutical production and supply chain.
As one of the country’s specialized pharmaceutical industry events, Iran Pharmex provides an opportunity to showcase manufacturing and technological capabilities, exchange knowledge, develop specialized and commercial partnerships, and identify export opportunities.
The participation of Golrang Pharmaceutical Investment Group’s companies in this event is aimed at strengthening specialized and commercial cooperation and expanding domestic and international markets across the pharmaceutical production and supply chain.
